Patents by Inventor Maarten H. D. Postema

Maarten H. D. Postema has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chlorotoxin agents and uses thereof
    Patent number: 11826399
    Abstract: The present invention provides, among other things, compositions and methods relating to detection and/or treatment cancer (e.g., one or more tumors) that expresses Neuropilin 1 (NRP1). The present invention provides methods of treating cancer that include administering a chlorotoxin agent to a subject (e.g., to a subject suffering from or susceptible to the cancer which may, in some embodiments, be a cancer that expresses NRP1). In some embodiments, a chlorotoxin agent for use in accordance with the present invention can be or comprise a chlorotoxin polypeptide and a payload moiety (e.g., as a covalent conjugate).
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: November 28, 2023
    Assignee: Eisai Inc.
    Inventors: Sharon McGonigle, Utpal Majumder, Maarten H. D. Postema
  • CHLOROTOXIN AGENTS AND USES THEREOF
    Publication number: 20200206312
    Abstract: The present invention provides, among other things, compositions and methods relating to detection and/or treatment cancer (e.g., one or more tumors) that expresses Neuropilin 1 (NRP1). The present invention provides methods of treating cancer that include administering a chlorotoxin agent to a subject (e.g., to a subject suffering from or susceptible to the cancer which may, in some embodiments, be a cancer that expresses NRP1). In some embodiments, a chlorotoxin agent for use in accordance with the present invention can be or comprise a chlorotoxin polypeptide and a payload moiety (e.g., as a covalent conjugate).
    Type: Application
    Filed: September 14, 2018
    Publication date: July 2, 2020
    Inventors: Sharon McGonigle, Utpal Majumder, Maarten H. D. Postema